Premium
Haploinsufficiency of the basic helix–loop–helix transcription factor HAND2 causes congenital heart defects
Author(s) -
Cohen Ana S. A.,
Simotas Christopher,
Webb Bryn D.,
Shi Huanzhi,
Khan Wahab A.,
Edelmann Lisa,
Scott Stuart A.,
Singh Ram
Publication year - 2020
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.61537
Subject(s) - haploinsufficiency , genetics , proband , biology , heart development , heart disease , atrioventricular canal , medicine , gene , mutation , phenotype , embryonic stem cell
Congenital heart defects (CHDs) are caused by a disruption in heart morphogenesis, which is dependent, in part, on a network of transcription factors (TFs) that regulate myocardial development. Heterozygous sequence variants in the basic helix–loop–helix TF gene heart and neural crest derivatives expressed 2 ( HAND2) have been reported among some patients with CHDs; however, HAND2 has not yet been established as a Mendelian disease gene. We report a 31‐month‐old male with unicommissural unicuspid aortic valve, moderate aortic stenosis, and mild pulmonic stenosis. Chromosome analysis revealed a normal 46,XY karyotype, and a CHD sequencing panel was negative for pathogenic variants in NKX2.5 , GATA4 , TBX5 , and CHD7 . However, chromosomal microarray (CMA) testing identified a heterozygous 546.0‐kb deletion on chromosome 4q34.1 (174364195_174910239[GRCh37/hg19]) that included exons 1 and 2 of SCRG1 , HAND2 , and HAND2‐AS1 . Familial CMA testing determined that the deletion was paternally inherited, which supported a likely pathogenic classification as the proband's father had previously undergone surgery for Tetralogy of Fallot. The family history was also notable for a paternal uncle who had previously died from complications related to an unknown heart defect. Taken together, this first report of a HAND2 and HAND2‐AS1 deletion in a family with CHDs strongly supports haploinsufficiency of HAND2 as an autosomal dominant cause of CHD.